Uniplan Investment Counsel’s American Healthcare REIT AHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.94M Sell
133,114
-4,914
-4% -$241K 0.65% 46
2026
Q1
$6.51M Buy
138,028
+26,567
+24% +$1.32M 0.67% 41
2025
Q4
$5.25M Buy
111,461
+65,306
+141% +$3.03M 0.53% 52
2025
Q3
$1.94M Sell
46,155
-708
-2% -$28.5K 0.19% 114
2025
Q2
$1.72M Sell
46,863
-4,758
-9% -$158K 0.17% 109
2025
Q1
$1.56M Sell
51,621
-1,834
-3% -$52.9K 0.15% 115
2024
Q4
$1.52M Buy
+53,455
New +$1.44M 0.14% 115

Other funds holding AHR

Uniplan Investment Counsel's AHR Position: Q2 2026 in Review

Uniplan Investment Counsel reduced its American Healthcare REIT (AHR) stake by 3.6% in Q2 2026, selling an estimated $241K and leaving 133,114 shares worth $6.94M. The position accounts for 0.65% of the portfolio, ranked #46.

Uniplan Investment Counsel first reported a position in AHR in Q4 2024 and has held it in 7 quarters since. 571 funds tracked by Wall St. Rank hold AHR as of Q2 2026.

  • Uniplan Investment Counsel held 133,114 shares of American Healthcare REIT worth $6.94M as of Q2 2026.
  • Uniplan Investment Counsel sold 4,914 American Healthcare REIT shares in Q2 2026, an estimated $241K.
  • American Healthcare REIT made up 0.65% of Uniplan Investment Counsel's portfolio in Q2 2026, its #46 holding.
  • Uniplan Investment Counsel first reported a position in American Healthcare REIT in Q4 2024 and has held it in 7 quarters since.
  • 571 funds tracked by Wall St. Rank held American Healthcare REIT as of Q2 2026.

Based on Uniplan Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.